Concepedia

Philippe Couttet

PC

Statistics

Publications

29

Citations

3.7K

H-Index

23

Active since

1997

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Bayer (Germany)

National Institutes of Health

Philippe Couttet is an author at Novartis (Switzerland) specializing in life sciences, molecular biology, and gene expression.

ORCID

Publications per year

1997–2023

29

Publications

29

Requirement of <i>bic/microRNA-155</i> for Normal Immune Function

Antony Rodriguez, Elena Vigorito, Simon Clare et al. · Science · 2007 · 1.8K citations · Full text

, , +17

The landscape of histone modifications across 1% of the human genome in five human cell lines

Robert Andrews, Paul Flicek, Shane C. Dillon et al. · Genome Research · 2007 · 446 citations · Full text

, , +17

Messenger RNA deadenylylation precedes decapping in mammalian cells

Philippe Couttet, Micheline Fromont‐Racine, Diana M. Steel et al. · Proceedings of the National Academy of Sciences · 1997 · 206 citations · Full text

, , +15

Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4

Robin A. Fairhurst, Thomas Knoepfel, Nicole Buschmann et al. · Journal of Medicinal Chemistry · 2020 · 113 citations · Full text

, , +15

FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer

Andreas Weiss, Flavia Adler, Alexandra Buhles et al. · Molecular Cancer Therapeutics · 2019 · 102 citations

, , +16

1–5 of 29